Products for Research Use Only
RegisterLogin

(E) -CHBO4

CAT: 0804-HY-W083026-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W083026-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(E) -CHBO4 is a MAO-B inhibitor, with an IC50 of 0.023 μM, and can be used for research on the treatment of Parkinson's disease[1].
CAS Number
126473-61-8
UNSPSC
12352005
Hazard Statement
H226
Target
Monoamine Oxidase
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Purity
97.04
Smiles
FC(C=C1)=CC=C1/C=C/C(C2=CC=C(C=C2)Br)=O
Molecular Formula
C15H10BrFO
Molecular Weight
305.14
Precautions
H226
References & Citations
[1]Mohamed A. Abdelgawad, et al. Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease. Journal of Molecular Structure. Volume 1266, 15 October 2022, 133545.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MAO-B

Related Products

CatalogName
HY-155137-01CHBO4
HY-128978(E, E) -RAMB4
HY-Y0248-01(E, ​E) ​-​Farnesol
HY-114770(E, E) -GLL398
HY-N0007-01(E, E) -Bisdemethoxycurcumin
HY-W019710-01(E, E) -RGFP966
HY-131520(E, E, E) -Farnesyl alcohol azide
HY-N12873(E, E, E, ) -10,12,14-Hexadecatrienal
HY-Y0248R-01(E, E) -Farnesol (Standard)
HY-W749519(E, E) -Farnesol-13C3

Alternative Products

CatalogName
MBS5819292CHBO4
GTR19249677-01(E) -CHBO4

Popular Products